To Combine: VEGF + PD-1
David McDermott, MD, Leader, Kidney Cancer Program<br />Dana-Farber/Harvard Cancer Center presents To Combine: VEGF + PD-1 at the 2016 annual International Kidney Cancer Symposium.<br /> Author: kidneycancer Added: 11/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2016 Category: Cancer & Oncology Source Type: podcasts

Phase 3 Perioperative Nivolumab in M0 RCC (PROSPER RCC, ECOG ACRIN 8143)
Lauren C. Harshman MD, Assistant Professor of Medicine, Harvard Medical School, Dana-Farber, presents a strong case for a neoadjuvant/adjvuant approach to priming the immune system before surgery at t... Author: kidneycancer Added: 11/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2016 Category: Cancer & Oncology Source Type: podcasts

The High Cost of Prescription Drugs in the United States
Drug prices continue to rise in the US. Many solutions have been proposed but few have been implemented. Drs. Janet Woodcock from the FDA and Aaron Kesselheim, author of The High Cost of Prescription Drugs in the United States from the Harvard Medical School discuss the role of brand name drugs and generics and how they influence the cost of pharmaceuticals. Also see The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions by Thomas A. Abbott and John A. Vernon. (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - August 26, 2016 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

The High Cost of Pharmaceuticals in the United States
Drug prices continue to rise in the US. Many solutions have been proposed but few have been implemented. Drs. Janet Woodcock from the FDA and Aaron Kesselheim, author of The High Cost of Prescription Drugs in the United States from the Harvard Medical School discuss the role of brand name drugs and generics and how they influence the cost of pharmaceuticals. Also see The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions by Thomas A. Abbott and John A. Vernon. (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - August 26, 2016 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

Episode 36: Challenging Common Knowledge
Inside the mind of physician-economist Bapu Jena (Source: Harvard Medical Labcast)
Source: Harvard Medical Labcast - August 12, 2016 Category: Biomedical Science Authors: Harvard Medical School Office of Communications and External Relations Source Type: podcasts

" Vitamin Spired " -- The Discovery Files
Harvard researchers have identified a whole new class of high-performing organic molecules, inspired by vitamin B2, that can safely store electricity from intermittent energy sources like solar and wind power in large batteries. (Source: The Discovery Files)
Source: The Discovery Files - August 9, 2016 Category: Science Authors: National Science Foundation Source Type: podcasts

Episode 35: Connecting the Dots
Improving transgender health care by unifying efforts across HMS (Source: Harvard Medical Labcast)
Source: Harvard Medical Labcast - June 22, 2016 Category: Biomedical Science Authors: Harvard Medical School Office of Communications and External Relations Source Type: podcasts

Advances in the clinical management of MM
At the 2016 World Congress of the International Society of Hematology (ISH) held in Glasgow, Scotland, Paul Richardson, MD, from the Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA gi... Author: VJHemOnc Added: 05/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2016 Category: Cancer & Oncology Source Type: podcasts

Is My Family at Risk If I Have Lung Cancer?
What causes lung cancer? Can it be passed on genetically? Lung cancer experts Dr. George Simon of MD Anderson Cancer Center and Dr. Rebecca Heist of Harvard Medical Center discuss various common cause... Author: P2Professional Added: 05/12/2016 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2016 Category: Cancer & Oncology Source Type: podcasts

Medicine's Future, From a Leader in Genome Editing and Stem Cells
Eric Topol speaks with Chad Cowan, of the Harvard Stem Cell Institute, about how regenerative medicine may soon cure diseases like type 1 diabetes and Parkinson disease. (Source: Medscape Med Students Podcast)
Source: Medscape Med Students Podcast - May 10, 2016 Category: Universities & Medical Training Authors: Medscape Source Type: podcasts

Medicine's Future, From a Leader in Genome Editing and Stem Cells
Eric Topol speaks with Chad Cowan, of the Harvard Stem Cell Institute, about how regenerative medicine may soon cure diseases like type 1 diabetes and Parkinson disease. (Source: Medscape Family Medicine Podcast)
Source: Medscape Family Medicine Podcast - May 10, 2016 Category: Primary Care Authors: Medscape Source Type: podcasts

Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents
Attention-Deficit/Hyperactivity Disorder, or ADHD is a very common problem affecting about 10% of all adolescents. Children with ADHD have short attention spans, are hyperactive, talk a great deal, can be disruptive in the classroom etc.-features that are common in many adolescents. However, to have true ADHD, children must be significantly impaired by these problems. An array of medical and behavioral treatments can successfully help manage ADHD. These are reviewed in a series of articles appearing in the May 10, 2016, issue of JAMA. In this podcast, we discuss ADHD with the authors of some of those papers, Eugenia Chan, ...
Source: JAMA Author Interviews - May 10, 2016 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Treating ADHD in Adolescents
Attention-Deficit/Hyperactivity Disorder, or ADHD is a very common problem affecting about 10% of all adolescents. Children with ADHD have short attention spans, are hyperactive, talk a great deal, can be disruptive in the classroom etc.-features that are common in many adolescents. However, to have true ADHD, children must be significantly impaired by these problems. An array of medical and behavioral treatments can successfully help manage ADHD. These are reviewed in a series of articles appearing in the May 10, 2016, issue of JAMA. In this podcast, we discuss ADHD with the authors of some of those papers, Eugenia Chan, ...
Source: JAMA Author Interviews - May 10, 2016 Category: General Medicine Authors: The JAMA Network Source Type: podcasts